scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2141.1996.4611002.X |
P698 | PubMed publication ID | 8611466 |
P2093 | author name string | A Lubenko | |
M Contreras | |||
M J Seghatchian | |||
M Wadhwa | |||
R Thorpe | |||
P Dilger | |||
C Bird | |||
P2860 | cites work | Preliminary report: effects of interleukin-1 on platelet counts | Q33386263 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 225-234 | |
P577 | publication date | 1996-04-01 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays | |
P478 | volume | 93 |
Q24801336 | A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] |
Q33579626 | Are cytokines in platelet concentrates responsible for febrile transfusion reactions? |
Q55344331 | Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know. |
Q33579171 | Current methods for the preparation of platelet concentrates: laboratory and clinical aspects |
Q36676742 | Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment |
Q74107507 | Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction |
Q77137580 | Cytokines in platelet concentrates: a comparison of apheresis platelet (haemonetics) and filtered and unfiltered pooled buffy-coat derived platelet concentrates |
Q41342373 | Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods |
Q73808056 | Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood |
Q41661946 | Determining the Effect of Preparation and Storage: An Effort to Streamline Platelet Components as a Source of Growth Factors for Clinical Application |
Q40769014 | Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion |
Q98613211 | Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study |
Q43629600 | Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. |
Q40628811 | Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations |
Q44284536 | Functional lymphocyte immunophenotypes observed in thalassaemia and haemophilia patients receiving current blood product preparations |
Q33361167 | Optimizing platelet transfusion therapy |
Q34279813 | Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates |
Q39360814 | Platelet Derived Biomaterials for Therapeutic Use: Review of Technical Aspects |
Q45913574 | Platelet lysate promotes in vitro wound scratch closure of human dermal fibroblasts: different roles of cell calcium, P38, ERK and PI3K/AKT. |
Q24802383 | Problems in early diagnosis of bladder cancer in a spinal cord injury patient: report of a case of simultaneous production of granulocyte colony stimulating factor and parathyroid hormone-related protein by squamous cell carcinoma of urinary bladder |
Q73252026 | Single automated donor plateletpheresis increases the plasma level of proinflammatory cytokine tumor necrosis factor-alpha which does not associate with endothelial release markers von Willebrand factor and fibronectin |
Q35609782 | Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. |
Q50448800 | The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins. |
Q78859791 | The causes and treatment of reactions to platelet transfusions |
Q78833819 | The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage |
Q77137592 | The quality of clinical FFP, cryoprecipitate and cryosupernatant derived from single donor apheresis procedures and random donations collected in a BAT system: assessment of the activity states of FVIII, contact activation, microvesicle content and |
Search more.